CARLSBAD, Calif., Nov. 17, 2011 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced that the company has introduced its GeneArt® Algae Engineering Kits, the first commercially available genetic modification and expression systems for photosynthetic microalgae Chlamydomonas reinhardtii and Synechococcus elongatus. The strains are model organisms for the study of photosynthesis, circadian rhythms and nutrient-regulated gene activity, and are being investigated for bioproduction of biofuels, nutraceuticals and specialty chemicals.
The GeneArt® Chlamydomonas Engineering Kits and GeneArt® Synechoccus Engineering Kits combine optimized and fully characterized vectors, guaranteed pure and viable cells, specialty media for each strain and simple protocols to create the first standardized system for algae research and metabolic engineering. The algal strains contained in the kits are the first that can be shipped and stored frozen at -80 degrees Celsius, which simplifies their standardization and use.
Algal researchers have traditionally relied on cells, vectors, cloning tools and protocols that can be poorly defined, inferior or contaminated. Cells from these sources often ship on agar slants which frequently become tainted or have low survival rates. Additionally, vectors from uncontrolled sources often contain undocumented changes. The GeneArt vectors facilitate rapid, directional cloning of synthetic genes or PCR products and serve dual purpose for both engineering and expression. Gibco® media is optimized for each strain and provided at 1X concentration, eliminating laborious and time-consuming media preparation.
"The lack of pure, uniform cultures and standardized growth media has made work with algae cumbersome and difficul
|SOURCE Life Technologies Corporation|
Copyright©2010 PR Newswire.
All rights reserved